DEXAMETHASONE SODIUM PHOSPHATE 4mg/ml Injection/Solution for Price, Uses, Alternatives, Dose, and more in UAE 2023
DEXAMETHASONE SODIUM PHOSPHATE 4mg/ml Injection/Solution for
416
AED 85
Drug name DEXAMETHASONE SODIUM PHOSPHATE 4mg/ml
Active substance Dexamethasone Sodium Phosphate
Size : 1ml Ampoule x 50
Concentration: 4mg/ml
Type: Injection/Solution for
Company : DAVID BULL LABORATORIES
Import: AUSTRALIA
Uploaded By : Admin
ٍ Visits : 416 visit
Dexamethasone sodium phosphate
Dexamethasone is a corticosteroid that prevents the release of substances that cause inflammation in the body. Dexamethasone is used to treat many different inflammatory diseases such as allergic disorders and skin conditions. Dexamethasone is also used to treat ulcerative colitis, arthritis, lupus, psoriasis, and breathing disorders.
Warnings when taking dexamethasone sodium phosphate Contraindications/Warnings Contraindications
Fungal diseases of the ear (eye points) Fungal infections Hypersensitivity to dexamethasone, sulfites, or any other component of this product Eye or surrounding eye infections, including viral diseases of the cornea and conjunctiva, including herpes simplex virus keratitis Active, chicken pox, and fungal diseases (eye points) Perforation of the tympanic membrane (eye points)
Precautions
Hypertension, sodium and water retention, and increased potassium excretion may occur in moderate and large doses; hypothyroidism; Enhances corticosteroid effect Spinal cord infarction, paraplegia and quadriplegia, cortical blindness, stroke, convulsions, cerebral edemaProlonged use may lead to ocular hypertension and/or glaucoma, defects in visual acuity and fields of visionProlonged use may cause corneal thinningProlonged use in Children may suppress growth
Side Effects of Dexamethasone Sodium Phosphate
Side Effects CommonCardiovascular: fluid retention, high blood pressureSkin: skin irritationMetabolic and Endocrine: Cushing s syndrome, decreased body growthPsychological diseases: depressionRespiratory system: pulmonary tuberculosis
Welcome to Dwaey, specifically on DEXAMETHASONE SODIUM PHOSPHATE 4mg/ml Injection/Solution for page.
This medicine contains an important and useful components, as it consists of Dexamethasone Sodium Phosphate.
DEXAMETHASONE SODIUM PHOSPHATE 4mg/ml is available in the market in concentration 4mg/ml and in the form of Injection/Solution for.
DAVID BULL LABORATORIES is the producer of DEXAMETHASONE SODIUM PHOSPHATE 4mg/ml and it is imported from AUSTRALIA.
The most popular alternatives of DEXAMETHASONE SODIUM PHOSPHATE 4mg/ml are listed downward .
Lets know how to use DEXAMETHASONE SODIUM PHOSPHATE 4mg/ml Injection/Solution for
Systemic fungal infections . Hypersensitivity to any component of this product, including sulfites
This product, like many other steroid formulations, is sensitive to heat. Therefore, it should not be autoclaved when it is desirable to sterilize the exterior of the vial. Following prolonged therapy, withdrawal of corticosteroids may result in symptoms of the corticosteroid withdrawal syndrome including fever, myalgia, arthralgia, and malaise. This may occur in patients even without evidence of adrenal insufficiency. There is an enhanced effect of corticosteroids in patients with hypothyroidism and in those with cirrhosis. Corticosteroids should be used cautiously in patients with ocular herpes simplex for fear of corneal perforation. The lowest possible dose of corticosteroid should be used to control the condition under treatment, and when reduction in dosage is possible, the reduction must be gradual. Psychic derangements may appear when corticosteroids are used, ranging from euphoria, insomnia, mood swings, personality changes, and severe depression to frank psychotic manifestations. Also, existing emotional instability or psychotic tendencies may be aggravated by corticosteroids. Aspirin should be used cautiously in conjunction with corticosteroids in hypoprothrombinemia. Steroids should be used with caution in nonspecific ulcerative colitis, if there is a probability of impending perforation, abscess, or other pyogenic infection, also in diverticulitis, fresh intestinal anastomoses, active or latent peptic ulcer, renal insufficiency, hypertension, osteoporosis, and myasthenia gravis. When large doses are given, some authorities advise that antacids be administered between meals to help to prevent peptic ulcer. Growth and development of infants and children on prolonged corticosteroid therapy should be carefully followed. Steroids may increase or decrease motility and number of spermatozoa in some patients. Phenytoin, phenobarbital, ephedrine, and rifampin may enhance the metabolic clearance of corticosteroids resulting in decreased blood levels and lessened physiologic activity, thus requiring adjustment in corticosteroid dosage. These interactions may interfere with dexamethasone suppression tests which should be interpreted with caution during administration of these drugs. When corticosteroids are administered concomitantly with potassium-depleting diuretics, patients should be observed closely for development of hypokalemia. Intra-articular injection of a corticosteroid may produce systemic as well as local effects. Lactation: Drug excreted in breast milk; not recommended
Dexamethasone is a synthetic glucocorticoid which decreases inflammation by inhibiting the migration of leukocytes and reversal of increased capillary permeability. It suppresses normal immune response.
Increased risk of hypokalaemia when used concurrently with potassium-depleting drugs such as amphotericin B and loop diuretics. Reduces efficacy of isoniazid, salicylates, vaccines and toxoids. Increased activity of dexamethasone and cyclosporin when used together. Concurrent use with aspirin or ethanol may lead to increased GI side effects. Potentially Fatal: Reduced efficacy in combination with ephedrine, cholestyramine, phenytoin, phenobarbital and rifampicin.